Funding · Company
Hexagon Bio Inc.
Menlo Park, CABiotech & Pharma
Hexagon Bio Inc. of Menlo Park, CA has disclosed $128M across 2 Form D offerings filed with the SEC between Jul 19, 2021 and Oct 11, 2022.
$128M
Total disclosed
2
Form D offerings
2016
Incorporated
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$67M
Form D · Oct 11, 2022 ↗
Q4 2022
· target $80M
Filing details
HeadquartersMenlo Park, CAIndustryBiotech & Pharma (Biotechnology)Incorporated2016SEC CIK0001712416Offerings on file2
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →